Literature DB >> 4941403

Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

K E Osserman, G Genkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4941403

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


× No keyword cloud information.
  117 in total

1.  Monitoring muscle weakness in neonatal myasthenia gravis.

Authors:  A A Hutchison; D J Lloyd; G Russell
Journal:  Br Med J       Date:  1975-12-13

2.  Letter: Measurement of neonatal growth.

Authors: 
Journal:  Br Med J       Date:  1975-04-05

3.  Quality of life and life circumstances in German myasthenia gravis patients.

Authors:  Sabine Twork; Susanne Wiesmeth; Jörg Klewer; Dieter Pöhlau; Joachim Kugler
Journal:  Health Qual Life Outcomes       Date:  2010-11-11       Impact factor: 3.186

Review 4.  Pediatric thymomas: report of two cases and comprehensive review of the literature.

Authors:  Annabelle L Fonseca; Doruk E Ozgediz; Emily R Christison-Lagay; Frank C Detterbeck; Michael G Caty
Journal:  Pediatr Surg Int       Date:  2013-12-10       Impact factor: 1.827

5.  Dysphagia in the elderly.

Authors:  Muhammad Aslam; Michael F Vaezi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-12

Review 6.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

7.  Postoperative management after thymectomy.

Authors:  A B Loach; A C Young; J M Spalding; A C Smith
Journal:  Br Med J       Date:  1975-02-08

8.  Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.

Authors:  A Rødgaard; F C Nielsen; R Djurup; F Somnier; S Gammeltoft
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

Review 9.  Thymectomy in myasthenia gravis. A review.

Authors:  H J Oosterhuis
Journal:  Ital J Neurol Sci       Date:  1983-12

10.  Surgical treatment for myasthenia gravis.

Authors:  T J Otto; H Strugalska
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.